SRBT Stock Overview
Shanrong Biotechnology Corp. operates as a project management and executive consulting company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Shanrong Biotechnology Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.37 |
| 52 Week High | US$0.90 |
| 52 Week Low | US$0.19 |
| Beta | 0 |
| 1 Month Change | -58.42% |
| 3 Month Change | n/a |
| 1 Year Change | -27.45% |
| 3 Year Change | 640.00% |
| 5 Year Change | -41.27% |
| Change since IPO | -99.75% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SRBT | US Aerospace & Defense | US Market | |
|---|---|---|---|
| 7D | -58.4% | -0.2% | -3.2% |
| 1Y | -27.5% | 15.2% | 19.3% |
Return vs Industry: SRBT underperformed the US Aerospace & Defense industry which returned 15.2% over the past year.
Return vs Market: SRBT underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| SRBT volatility | |
|---|---|
| SRBT Average Weekly Movement | n/a |
| Aerospace & Defense Industry Average Movement | 5.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SRBT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SRBT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Timothy Ringgold | n/a |
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services. It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets.
Shanrong Biotechnology Corp. Fundamentals Summary
| SRBT fundamental statistics | |
|---|---|
| Market cap | US$179.40k |
| Earnings (TTM) | -US$2.07k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs SRBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRBT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.07k |
| Earnings | -US$2.07k |
Last Reported Earnings
Dec 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SRBT perform over the long term?
See historical performance and comparison